 The study aimed to determine the prevalence and association between long COVID symptoms and Epstein-Barr virus, EBV, reactivation in COVID-19 patients. Out of 185 surveyed patients, 30.3 percent experienced long COVID symptoms, including four initially asymptomatic patients who later developed symptoms. In a primary study group of 68 patients, 66.7 percent of long COVID subjects were positive for EBV reactivation based on positive titers for EBV early antigen diffuse, EAD, IgG or EBV viral capsid antigen, VCA, IgM. This was significantly different from the 10 percent of control subjects who tested positive for EBV reactivation, P less than 0.001, Fisher's exact test. A similar ratio was observed in a secondary group of 18 patients tested 21 to 90 days after COVID-19 infection, suggesting that many long COVID symptoms may be the result of COVID-19 inflammation-induced EBV reactivation. This article was authored by Jeffrey E. Gold, Ramazan Aokaiye, Warren E. Licht and others. We are article.tv. Links in the description below.